Investment Rating - The report maintains an optimistic outlook on the pharmaceutical industry, particularly for 2025, suggesting a potential for diverse investment opportunities as the sector recovers from low valuations and public fund allocations [10]. Core Insights - The pharmaceutical sector is currently experiencing low valuations, with public funds under-allocating to this area. The report anticipates a recovery driven by macroeconomic factors and significant product launches [10]. - The report emphasizes a shift in the innovative drug sector from quantity to quality, highlighting the importance of differentiated products and international expansion for profitability [10]. - The medical device sector is seeing a rebound in bidding volumes, particularly in imaging equipment, and is expected to benefit from domestic product upgrades and international market expansion [10]. - The report identifies a growing trend in the CXO and life sciences services sector, with expectations for increased investment and a recovery in demand [10]. - The traditional Chinese medicine sector is projected to benefit from policy changes and market dynamics, with specific companies recommended for investment based on their unique product offerings and market positions [12]. Summary by Sections Market Review - The report notes a 1.80% increase in the CITIC Pharmaceutical Index, outperforming the CSI 300 Index by 0.98 percentage points, ranking 16th among 30 sectors [7]. - The top-performing stocks include Frontline Bio-U, MediWest, and Lianhuan Pharmaceutical, while the worst performers include ST Weiming and Innovent Biologics [7]. Overall Perspective and Investment Themes - The report suggests that the pharmaceutical industry is poised for growth, with a focus on innovative drugs, medical devices, and traditional Chinese medicine. Specific companies are highlighted for their potential in these areas [10][12]. - The report also discusses the implications of policy changes and market trends for the pharmaceutical and medical device sectors, indicating a favorable environment for investment [10][12]. Company-Specific Insights - Companies like Baiyi, Xinda, and Kangfang are highlighted for their innovative drug pipelines and potential for growth in the coming years [10][12]. - The report provides detailed insights into the clinical progress of various drugs across different companies, indicating a robust pipeline that could drive future revenue [13][20][24][30][35][38].

Report Industry Investment Rating No relevant content provided. Core Viewpoints - On July 11, 2025, most convertible bond industries rose, and the valuation increased month - on - month. The trading sentiment in the convertible bond market weakened [1]. - The convertible bond price center increased, and the proportion of high - price bonds decreased. The convertible bond valuation increased [2]. - In the stock market, more than half of the underlying stock industry indices rose. In the convertible bond market, 22 industries rose [3]. Summary by Directory 1. Market Main Index Performance - The CSI Convertible Bond Index rose 0.03% month - on - month, the Shanghai Composite Index rose 0.01%, the Shenzhen Component Index rose 0.61%, the ChiNext Index rose 0.80%, the SSE 50 Index fell 0.01%, and the CSI 1000 Index rose 0.85% [1]. - Small - cap growth stocks were relatively dominant. The large - cap growth index rose 0.55%, the large - cap value index fell 0.80%, the mid - cap growth index rose 0.28%, the mid - cap value index fell 0.13%, the small - cap growth index rose 0.68%, and the small - cap value index rose 0.18% [1]. 2. Market Fund Performance - The trading volume in the convertible bond market was 66.069 billion yuan, a 1.25% month - on - month decrease. The total trading volume of the Wind All - A Index was 1736.61 billion yuan, a 14.62% month - on - month increase. The net outflow of the main funds in the Shanghai and Shenzhen stock markets was 14.038 billion yuan [1]. - The yield of the 10 - year treasury bond rose 0.37bp month - on - month to 1.67% [1]. 3. Convertible Bond Valuation - After excluding convertible bonds with a closing price > 150 yuan and a conversion premium rate > 50%, the fitted conversion premium rate of 100 - yuan par value was 25.38%, a 0.08pct month - on - month increase. The overall weighted par value was 94.40 yuan, a 0.52% month - on - month decrease [2][21]. - The conversion premium rates of all types of convertible bonds (divided by stock - bond nature) increased. The conversion premium rate of equity - biased convertible bonds rose 1.23pct, that of debt - biased convertible bonds rose 0.39pct, and that of balanced convertible bonds rose 0.34pct [2]. 4. Industry Performance - In the A - share market, the top three rising industries were non - bank finance (+2.02%), computer (+1.93%), and steel (+1.93%); the top three falling industries were bank (-2.41%), building materials (-0.67%), and coal (-0.60%) [3]. - In the convertible bond market, 22 industries rose. The top three rising industries were non - bank finance (+1.97%), computer (+1.09%), and non - ferrous metals (+1.05%); the top three falling industries were bank (-0.72%), textile and apparel (-0.44%), and media (-0.27%) [3]. - In terms of closing price, the large - cycle sector rose 0.81%, the manufacturing sector rose 0.05%, the technology sector fell 0.22%, the large - consumption sector rose 0.12%, and the large - finance sector rose 0.66% [3]. - In terms of conversion premium rate, the large - cycle sector rose 0.45pct, the manufacturing sector rose 0.35pct, the technology sector fell 0.22pct, the large - consumption sector rose 0.31pct, and the large - finance sector rose 1.2pct [3]. - In terms of conversion value, the large - cycle sector rose 0.18%, the manufacturing sector fell 0.18%, the technology sector rose 0.43%, the large - consumption sector rose 0.22%, and the large - finance sector rose 0.71% [3]. - In terms of pure - bond premium rate, the large - cycle sector rose 0.53pct, the manufacturing sector rose 0.15pct, the technology sector rose 0.59pct, the large - consumption sector rose 0.13pct, and the large - finance sector rose 0.71pct [4]. 5. Industry Rotation - Non - bank finance, computer, and steel led the rise. The daily increase of non - bank finance in the underlying stock market was 2.02%, and 1.97% in the convertible bond market; the daily increase of computer was 1.93% in the underlying stock market and 1.09% in the convertible bond market; the daily increase of steel was 1.93% in the underlying stock market and 0.13% in the convertible bond market [56].

证 券 研 究 报 告 赛力斯（601127）2025 年半年度业绩预告点评 强推（维持） | | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业总收入(百万) | 145,176 | 176,843 | 188,834 | 216,434 | | 同比增速(%) | 305.0% | 21.8% | 6.8% | 14.6% | | 归母净利润(百万) | 5,946 | 11,706 | 13,068 | 16,639 | | 同比增速(%) | 342.7% | 96.9% | 11.6% | 27.3% | | 每股盈利(元) | 3.64 | 7.17 | 8.00 | 10.19 | | 市盈率(倍) | 38 | 19 | 17 | 14 | | 市净率(倍) | 18.4 | 7.4 | 5.7 | 4.3 | 资料来源：公司公告，华创证券预测 注：股价为 2025 年 7 月 10 日收盘价 公司研究 乘用车Ⅲ 2025 年 07 月 11 日 | 目标价：179.17 | 元 | | --- | -- ...

证 券 研 究 报 告 希荻微（688173）深度研究报告 强推（首次） 模拟行业复苏扬帆，外延并购拓平台版图 公司研究 集成电路 2025 年 07 月 11 日 目标价：17.91 元 当前价：13.41 元 华创证券研究所 证券分析师：耿琛 电话：0755-82755859 邮箱：gengchen@hcyjs.com 执业编号：S0360517100004 证券分析师：岳阳 邮箱：yueyang@hcyjs.com 执业编号：S0360521120002 证券分析师：吴鑫 邮箱：wuxin@hcyjs.com 执业编号：S0360523060001 联系人：卢依雯 邮箱：luyiwen@hcyjs.com 公司基本数据 | 总股本(万股) | 41,031.93 | | --- | --- | | 已上市流通股(万股) | 24,318.23 | | 总市值(亿元) | 55.02 | | 流通市值(亿元) | 32.61 | | 资产负债率(%) | 12.89 | | 每股净资产(元) | 3.57 | | 12 个月内最高/最低价 | 15.24/7.94 | 市场表现对比图(近 12 个月) - ...

证 券 研 究 报 告 非银金融行业深度研究报告 从铸币到流通：稳定币生态拆解 推荐（维持） ——稳定币系列报告之一 行业研究 非银行金融 2025 年 07 月 11 日 证券分析师：徐康 电话：021-20572556 邮箱：xukang@hcyjs.com 执业编号：S0360518060005 联系人：崔祎晴 邮箱：cuiyiqing@hcyjs.com 行业基本数据 华创证券研究所 | | | 占比% | | --- | --- | --- | | 股票家数(只) | 71 | 0.01 | | 总市值(亿元) | 73,466.14 | 6.95 | | 流通市值(亿元) | 56,759.47 | 6.82 | 相对指数表现 | % | 1M | 6M | 12M | | --- | --- | --- | --- | | 绝对表现 | 8.5% | 13.3% | 50.4% | | 相对表现 | 4.8% | 5.9% | 33.4% | -8% 18% 44% 69% 24/07 24/09 24/12 25/02 25/04 25/07 2024-07-10~2025-07-10 非银行 ...

证 券 研 究 报 告 南华期货（603093）重大事项点评 推荐（维持） 跨境清算牌照再扩容 目标价：30.76 元 事项： 公司研究 其他非银金融 2025 年 07 月 11 日 | | | 华创证券研究所 证券分析师：徐康 电话：021-20572556 邮箱：xukang@hcyjs.com 执业编号：S0360518060005 证券分析师：刘潇伟 邮箱：liuxiaowei@hcyjs.com 执业编号：S0360525020001 公司基本数据 《南华期货（603093）重大事项点评：拟赴港上 市，高筑境外业务护城河》 2025-01-21 证监会审核华创证券投资咨询业务资格批文号：证监许可（2009）1210 号 [ReportFinancialIndex] | 总股本(万股) | 61,006.59 | | --- | --- | | 已上市流通股(万股) | 61,006.59 | | 总市值(亿元) | 154.10 | | 流通市值(亿元) | 154.10 | | 资产负债率(%) | 89.41 | | 每股净资产(元) | 6.80 | | 12 个月内最高/最低价 | 25. ...

公司研究 证 券 研 究 报 告 Q2 经营韧性持续，国际化扩张打开成长空间 事项： 公司发布 2025 年半年度业绩预告：2025H1 公司实现归母净利润 4.63-4.71 亿 元，同比+6.06-7.80%，实现扣非归母净利润 4.36-4.43 亿元，同比+8.13%- 10.01%。 评论： [ReportFinancialIndex] 主要财务指标 | | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业总收入(百万) | 6,084 | 6,710 | 7,396 | 8,158 | | 同比增速(%) | 8.6% | 10.3% | 10.2% | 10.3% | | 归母净利润(百万) | 921 | 1,036 | 1,149 | 1,274 | | 同比增速(%) | 1.2% | 12.5% | 10.9% | 10.9% | | 每股盈利(元) | 0.55 | 0.62 | 0.68 | 0.76 | | 市盈率(倍) | 22 | 20 | 18 | 16 | | 市净率(倍) | 2.9 ...

【债券日报】 转债市场日度跟踪 20250710 ❖ 市场概况：今日转债跟随权益上涨，估值环比抬升 证 券 研 究 报 告 指数表现：中证转债指数环比上涨 0.40%、上证综指环比上涨 0.48%、深证成 指环比上涨 0.47%、创业板指环比上涨 0.22%、上证 50 指数环比上涨 0.62%、 中证 1000 指数环比上涨 0.25%。 转债价格：转债中枢提升，高价券占比提升。转债整体收盘价加权平均值为 124.13 元，环比昨日上升 0.43%。其中偏股型转债的收盘价为 164.25 元，环比 下降 0.91%；偏债型转债的收盘价为 115.18 元，环比上升 0.46%；平衡型转债 的收盘价为 124.13 元，环比上升 0.29%。从转债收盘价分布情况看，130 元以 上高价券个数占比 33.19%，较昨日环比上升 1.57pct；占比变化最大的区间为 100-110（包含 110），占比 3.19%，较昨日下降 1.08pct；收盘价在 100 元以下 的个券有 2 只。价格中位数为 125.74 元，环比昨日上升 0.51%。 转债估值：估值抬升。百元平价拟合转股溢价率为 25.30%，环比昨日 ...

Investment Rating - The report maintains a "Recommendation" rating for J&T Express (01519.HK) [1] Core Views - J&T Express reported a significant year-on-year increase of 66% in parcel volume in Southeast Asia for Q2, with an average daily volume of 18.5 million parcels [1][3] - The overall average daily parcel volume for the group reached 81.2 million, reflecting a year-on-year growth of 23.5% [1] - The company is expected to benefit from the strong growth of e-commerce platforms like TikTok in Southeast Asia, which is projected to reach a GMV of $128.4 billion by 2024 [1][2] - J&T Express has maintained its position as the leading express operator in Southeast Asia, with a market share of 28.6% in 2024, up 3.2 percentage points from 2023 [2][3] Summary by Sections Company Performance - In Q2, J&T Express's daily average parcel volume in Southeast Asia was 18.5 million, a 66% increase year-on-year, while the daily average volume in China reached 61.7 million, growing by 14.7% [1] - For the first half of the year, the total daily average parcel volume for the group was 76.9 million, up 26% year-on-year, with Southeast Asia showing a 57% increase [1] Market Dynamics - TikTok's e-commerce growth in Southeast Asia has been robust, with its GMV increasing from $4.4 billion in 2022 to $16.3 billion in 2023, and projected to reach $22.6 billion in 2024 [2] - J&T Express is positioned to benefit from the increasing parcel volumes driven by e-commerce growth, despite competition from platforms like Shopee and Lazada [2] Financial Projections - The target price for J&T Express is set at HKD 11.16, with the current price at HKD 8.39, indicating a potential upside of 33% [4] - Revenue projections for J&T Express are expected to grow from $10.26 billion in 2024 to $15.52 billion in 2027, with a compound annual growth rate of 15.9% [8]

证 券 研 究 报 告 康耐特光学（02276.HK）跟踪分析报告 强推（维持） Meta 收购依视路约 3%股份，重视智能眼镜 产业链机会 事项： ❖ 根据 Wind 资讯，Meta 以当前市价购入依视路近 3%的股份，价值约 30 亿欧 元（约 252 亿人民币）；而且之后可能考虑追加投资，将持股比例提升至 5%左 右。 评论： [ReportFinancialIndex] 主要财务指标 | | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业总收入(百万) | 2,061 | 2,498 | 2,982 | 3,554 | | 同比增速(%) | 16.1% | 21.2% | 19.4% | 19.2% | | 归母净利润(百万) | 428 | 556 | 695 | 862 | | 同比增速(%) | 31.0% | 29.9% | 24.9% | 24.1% | | 每股盈利(元) | 1.00 | 1.16 | 1.45 | 1.80 | | 市盈率(倍) | 36.2 | 31.4 | 25.1 | 20 ...